Sunday mornings are usually reserved for mimosas and walks of shame. But when we uncharacteristically got out of bed and onto our laptops this morning to do some work we were elated to learn some encouraging news on the Interwebs coming out of Spain regarding HIV. Read more about it after the jump.

San Francisco is set to make history in early 2012 when it begins offering gay men a controversial pre-exposure prophylaxis that has successfully prevented HIV transmission at high rates during clinical trials. Details follow. 

Today, some good news is coming out of the 6th International AIDS Society Conference on HIV Pathogens, Treatment, and Prevention in Rome. Researchers with the U.S.-based VirxSys Corporation announced some encouraging findings with their vaccine trial in monkeys. More after the jump.

We’ve become hyper-aware and –vigilant about being discriminated against in the arenas of military and social laws, but an under-the-radar area of GLBT exclusion is only now coming into focus: science and medical studies.

Researchers at Philadelphia’s Fox Chase Center have crunched the numbers to arrive at a startling discovery: nearly 1/6th of clinical trials explicitly exclude GLBT participants.

Such trials bring to light new cures, medicines and therapies, and with a greater understanding of the breadth of disparities between heterosexual and homosexual or transgender health (depression, anxiety, suicide, to name a few), this outcasting in the modern clinical profession is outrageous.

Reports ABC:

"The National Institute of Health...

The American Medical Association has issued its second prescription for the government this week. Following a pre-Veterans day plea for legislation to repeal Don't Ask, Don't Tell, the AMA has issued a resolution recommending that the government change the laws governing marijuana.

The decision was arrived at in Houston and officially requests that the federal classification of marijuana as a drug with no medical benefits be changed, so that clinical trials can take place.

From The Los Angeles Times:

"Despite more than 30 years of clinical research, only a small number of randomized, controlled trials have been conducted on smoked cannabis," said Dr. Edward Langston, an AMA board member, noting that the limited number of studies...